Bing Qi
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Antibiotics Pharmacokinetics and Efficacy
- Toxicology top 10%
Papers in
- Oncology 16
- Drug Transport and Resistance Mechanisms 8
- Co-authors
- Hai–Ling Qiao (6 shared papers)Yan Fang (5 shared papers)Na Gao (5 shared papers)Lin-Jing Jia (4 shared papers)Hiroshi Sugiya (8 shared papers)Pieter Annaert (10 shared papers)Dong Shang (6 shared papers)Junko Fujita‐Yoshigaki (5 shared papers)
In The Last Decade
Bing Qi
55 papers receiving 680 citations
Peers
Comparison fields: 5 of 97
- Pharmacology 136
- Toxicology 19
- Oncology 131
- Pharmacology 78
- Neurology 33
Countries citing papers authored by Bing Qi
This map shows the geographic impact of Bing Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing Qi more than expected).
Fields of papers citing papers by Bing Qi
This network shows the impact of papers produced by Bing Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing Qi. The network helps show where Bing Qi may publish in the future.
Co-authors
The 25 scholars most cited alongside Bing Qi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 85 | |
| 2 | 2005 | 50 | |
| 3 | 2017 | 47 | |
| 4 | 2015 | 32 | |
| 5 | 2021 | 28 | |
| 6 | 2014 | 27 | |
| 7 | 2022 | 24 | |
| 8 | 2019 | 22 | |
| 9 | 2019 | 20 | |
| 10 | 2010 | 20 | |
| 11 | 2018 | 20 | |
| 12 | 2016 | 20 | |
| 13 | 2020 | 19 | |
| 14 | 2009 | 19 | |
| 15 | 2016 | 18 | |
| 16 | 2007 | 18 | |
| 17 | 2018 | 14 | |
| 18 | 2018 | 13 | |
| 19 | 2018 | 13 | |
| 20 | 2014 | 12 |
About Bing Qi
Bing Qi is a scholar working on Oncology, Molecular Biology, Physiology, Surgery and Pharmacology, having authored 56 papers that have together received 685 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (8 papers), Pancreatitis Pathology and Treatment (6 papers), Pharmacological Effects and Toxicity Studies (6 papers), Liver Disease Diagnosis and Treatment (5 papers), Salivary Gland Disorders and Functions (5 papers), Pediatric Hepatobiliary Diseases and Treatments (3 papers), Alcohol Consumption and Health Effects (3 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). The work is most often cited by research in Pharmacology (136 citations), Toxicology (19 citations), Oncology (131 citations), Pharmacology (78 citations) and Neurology (33 citations). Bing Qi has collaborated with scholars based in China, Belgium and Japan. Frequent co-authors include Hai–Ling Qiao, Yan Fang, Na Gao, Lin-Jing Jia, Hiroshi Sugiya, Pieter Annaert, Dong Shang, Junko Fujita‐Yoshigaki, Takanori Narita and Qingkai Zhang. Their work appears in journals such as Neurological Sciences, The Journal of Medical Investigation, PLoS ONE, Archives of Oral Biology and Pharmaceutical Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.